Replay
is a California-based gene therapy company that provides solutions such as genome editing and writing for the healthcare industry... Read moreReplay
is a California-based gene therapy company that provides solutions such as genome editing and writing for the healthcare industry... Read more
Co-Founder & CEO
Lachlan MacKinnon
News
Jun 19, 2024
Pharamceutical Technology
Replay: SY-104 by Syena for Multiple Myeloma (Kahler Disease): Likelihood of Approval
May 01, 2024
Clinical Trials Arena
Replay: Replay wins IND clearance for PRAME T cell cancer therapy
Mar 11, 2024
GlobalNewswire
Press Release: Replay : Replay's cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
Dec 18, 2023
GlobalNewswire
Press Release: Replay : Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
Sep 22, 2023
Pharamceutical Technology
Replay: JURA Bio and Syena partner to develop TCR-based therapies
Jul 24, 2023
GlobalNewswire
Press Release: Replay : Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for multiple myeloma
Jun 20, 2023
Newswise
Press Release: Replay : MD Anderson and Replay announce FDA clearance of IND application for first-in-class TCR NK cell therapy for sarcoma
Feb 15, 2023
PharmaLive
Replay: Replay, MD Anderson partner to create first engineered cell therapy for solid tumors
Dec 14, 2022
GlobalNewswire
Press Release: Replay : Replay targets genetic brain disorders with new gene therapy company, Kaleibe, utilising big DNA HSV technology
Nov 29, 2022
Owler
Replay Holdings, LLC: Replay's revenue changed from $900K in Jul 2022 to $1M in Nov 2022
